Postmenopausal Tamoxifen Treatment and Endometrial Pathology
- 1 December 1994
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 49 (12) , 823-829
- https://doi.org/10.1097/00006254-199412000-00006
Abstract
Tamoxifen is widely used as adjuvant therapy for postmenopausal breast cancer patients with positive estrogen receptors. Data on a possible association of endometrial pathologies with tamoxifen treatment have been accumulating. In this review, we examine the current literature and include our own experience with this occurence. We recommend close supervision of these patients.Keywords
This publication has 0 references indexed in Scilit: